Friday, July 10, 2026

pharma · Refractory Partial Onset Epilepsy · Multiple Sclerosis

NEURAXPHARM AUSTRALIA PTY

NEURAXPHARM AUSTRALIA PTY trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Melbourne, AU HQ
11 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Employees
11
Programs
3
Drugs
17
Patents
0
Intelligence · Clinical Trials

NEURAXPHARM AUSTRALIA PTY clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to NEURAXPHARM AUSTRALIA PTY programs — each row shows trial ID, program name, phase, status, and indication.

NEURAXPHARM AUSTRALIA PTY trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for NEURAXPHARM AUSTRALIA PTY.

  1. NXPTEGO/23/P1-4 — Phase 1

    Clinical update
  2. GFC-BEMD-01-NXP/23 — Phase 1

    Clinical update
  3. NXPLEVE/24/P3-6 — Phase 3

    Clinical update

Trial registry

3 studies